Home » Topics » BioWorld Science

BioWorld Science
RSS

Sertoli Technologies formed to develop new technology

April 12, 1996

Vaqta gets the green light from FDA

April 12, 1996

Nisin in testing for Helicobacter infections

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

OraVax granted patent on H. pylori vaccine technology

April 12, 1996

Novel prostaglandin D2 agonists from Glaxo Wellcome

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

Merck & Co. describes fibrinogen antagonists

April 12, 1996

Fibrinogen antagonists from Yamanouchi

April 12, 1996

ATIII in development at Genzyme Transgenics

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...